Epstein-Barr virus (EBV) has been frequently documented in the putative neoplastic Hodgkin-Reed-Sternberg (HRS) cells, in lymph nodes from patients with Hodgkin's disease (HD). This association varies in different geographic areas and between industrialized and developing countries, as does the epid
Progressive transition of Epstein–Barr virus associated lymphoproliferative disease subtypes with the development of lung cancer
✍ Scribed by Kazuki Taoka; Yasuhito Nannya; Go Yamamoto; Takashi Sakatani; Satoshi Ota; Masashi Fukayama; Tsuyoshi Takahashi; Mineo Kurokawa
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 726 KB
- Volume
- 84
- Category
- Article
- ISSN
- 0361-8609
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
DNA from malignant cells is present in the serum/plasma of cancer patients and DNA from this source is amenable to analysis by polymerase chain reaction (PCR). In the present study, we evaluated whether Epstein-Barr virus (EBV) DNA is present in the serum of patients with EBV-associated Hodgkin's di
## BACKGROUND. The incidence of Hodgkin's disease (HD) in Korea and other Asian countries is much lower than in western countries and its association with the Epstein-Barr virus has not been well characterized. ## METHODS. We evaluated the clinical, morphologic, and immunohistochemical features o
## Background: Reports that have both evaluated the site-specific epstein-barr virus (ebv) infection and compared it with the expression of the ebv-related proto-oncogenes and tumor suppressor genes in the various cancers of head and neck are scarce. ## Methods: Thirty-eight nasopharyngeal carcin
## Abstract EBV genotypes of first‐ and second‐generation Chinese diagnosed with nasopharyngeal carcinoma in the United States were analyzed by PCR techniques. Previous studies showed a geographical distribution of genotypically distinct sub‐types of EBV. Viruses detected at a higher frequency amon